Clinical Trial Update: The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates the physiological effects of intranasal oxytocin on sarcopenic obesity across Phase 1 and Phase 2, with completed status and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging
• Obesity
• Sarcopenia
• Sarcopenic Obesity
• Sedentary Lifestyle

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: Sara Espinoza | Conditions: Obesity, Sarcopenic Obesity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-10-22